论文部分内容阅读
我们自2004年12月～2006年11月对住院急性心肌梗死病人,在溶栓抗凝等综合治疗基础上加用倍他乐克148例(治疗组)。与2002年3月-2004年11月住院的急性心肌梗死病人132例(对照组)进行对比研究,旨在探讨倍他乐克能否进一步降低死亡率及再梗死率。
We from December 2004 to November 2006 inpatients with acute myocardial infarction, combined with thrombolytic anticoagulation and other comprehensive treatment based on the addition of Betaloc 148 cases (treatment group). And 132 patients (control group) with acute myocardial infarction who were hospitalized from March 2002 to November 2004 were compared to explore whether Betalok can further reduce the mortality and reinfarction rate.